tiprankstipranks
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA

INMB Stock Latest News

INmune Bio Collaborates on TBI and Alzheimer’s Study
Company AnnouncementsINmune Bio Collaborates on TBI and Alzheimer’s Study
3h ago
8K
INMB
INmune Bio initiated with a Buy at Lucid Capital
PremiumThe Fly
INmune Bio initiated with a Buy at Lucid Capital
7d ago
INMB
INmune Bio to Attend RBC Healthcare Conference
PremiumCompany Announcements
INmune Bio to Attend RBC Healthcare Conference
27d ago
8K
INMB
Inmune Bio’s Promising Pipeline and Strategic Positioning Earns Buy Rating from Analyst
PremiumRatings
Inmune Bio’s Promising Pipeline and Strategic Positioning Earns Buy Rating from Analyst
28d ago
INMB
INmune Bio’s Earnings Call: Promise and Challenges
PremiumCompany Announcements
INmune Bio’s Earnings Call: Promise and Challenges
29d ago
INMB
INmune Bio Reports Q1 2025 Results and Updates
PremiumCompany AnnouncementsINmune Bio Reports Q1 2025 Results and Updates
1M ago
INMB
Inmune Bio Secures Favorable Patentability Opinion for CORDStrom™
Premium
Company Announcements
Inmune Bio Secures Favorable Patentability Opinion for CORDStrom™
2M ago
8K
INMB
INmune Bio receives favorable patentability opinion for CORDStrom platform
Premium
The Fly
INmune Bio receives favorable patentability opinion for CORDStrom platform
2M ago
INMB
INmune Bio partners with Cell, Gene Therapy Catapult to scale up CORDStrom
PremiumThe Fly
INmune Bio partners with Cell, Gene Therapy Catapult to scale up CORDStrom
2M ago
INMB
Inmune Bio Presents Alzheimer’s Trial Data at Conference
PremiumCompany Announcements
Inmune Bio Presents Alzheimer’s Trial Data at Conference
2M ago
8K
INMB
Inmune Bio’s Promising Alzheimer’s Treatment and Growth Potential: A Buy Recommendation by Thomas Shrader
PremiumRatings
Inmune Bio’s Promising Alzheimer’s Treatment and Growth Potential: A Buy Recommendation by Thomas Shrader
2M ago
INMB
Inmune Bio’s Promising Future: Buy Rating Backed by Key Data Releases and Innovative Approaches
PremiumRatings
Inmune Bio’s Promising Future: Buy Rating Backed by Key Data Releases and Innovative Approaches
2M ago
INMB
INmune Bio presents baseline demographics of participants in MINDFuL study
PremiumThe FlyINmune Bio presents baseline demographics of participants in MINDFuL study
2M ago
INMB
INmune Bio’s Earnings Call: Key Insights and Future Prospects
Premium
Company Announcements
INmune Bio’s Earnings Call: Key Insights and Future Prospects
2M ago
INMB
INmune Bio Reports 2024 Financial Results and Clinical Progress
Premium
Company Announcements
INmune Bio Reports 2024 Financial Results and Clinical Progress
2M ago
INMB
INMB Earnings this Week: How Will it Perform?
PremiumPre-Earnings
INMB Earnings this Week: How Will it Perform?
3M ago
INMB
INmune Bio Reports Promising Phase I/II Trial Results
PremiumCompany Announcements
INmune Bio Reports Promising Phase I/II Trial Results
3M ago
8K
INMB
INmune Bio price target raised to $30 from $22 at Maxim
PremiumThe Fly
INmune Bio price target raised to $30 from $22 at Maxim
4M ago
INMB
INmune Bio opens Phase II in high dose cohort of INKmune trial
PremiumThe Fly
INmune Bio opens Phase II in high dose cohort of INKmune trial
4M ago
INMB
Inmune Bio’s Strategic Advancements and Promising Clinical Trials Justify Buy Rating
PremiumRatingsInmune Bio’s Strategic Advancements and Promising Clinical Trials Justify Buy Rating
4M ago
INMB
INmune Bio price target raised to $23 from $22 at Scotiabank
Premium
The Fly
INmune Bio price target raised to $23 from $22 at Scotiabank
4M ago
INMB
Inmune Bio Secures License Agreement for CORDStrom Data
Premium
Company Announcements
Inmune Bio Secures License Agreement for CORDStrom Data
4M ago
8K
INMB

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >